Gregor Diagnostics
MADISON, WI · Biotechnology · 9 employees
Gregor Diagnostics is a molecular diagnostics company developing a revolutionary new screening test for prostate cancer.
Funding history
- Funding Round — $242K — Nov 2025
- Funding Round — $7.4M — Dec 2024
- Series seed — $4.4M — Oct 2023
- Funding Round — $5.0M — Oct 2021
- Funding Round — $916K — Oct 2019
Recent signals
- Nov 04, 2025: Raised $242K
- Dec 16, 2024: Raised $7.4M
- Oct 31, 2023: Raised $4.4M in Series seed
- Oct 29, 2021: Raised $5.0M
- Oct 28, 2019: Raised $916K
- Jul 12, 2018: Raised $7.4M
See plans & pricing → Track Gregor Diagnostics’s funding, hiring, and signals — with verified contacts — on Fundz.